Article
RSPO3 is a marker candidate for predicting tumor aggressiveness in ovarian cancer
1 Nov 2020
Abstract excerpt
BACKGROUND: Ovarian cancer, a highly aggressive and heterogeneous gynecological malignancy that has long been difficult for physicians to identify and treat, requires more effective and precise molecular targets. R-spondin 3 (RSPO3) is a secreted protein that plays a tumorigenic role in several human cancers. However, the functional contribution and prognostic role of RSPO3 in ovarian cancer remain unclear....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
